Delivery Order SPE2DB22D1106-SPE2DB24FEXS1

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $7,667.38 delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide a comprehensive range of...
This federal contract award is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $3,007.71 contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S pharmaceutical products. Amerisourcebergen is a major supplier of pharmaceutical and medical supplies to the U.S. government, with extensive Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice Federal Bureau of Investigation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of RINVOQ ER 30 MG TABLET medication. The contract, valued at $6,164.01, is a firm fixed price delivery order with a completion date of July 1, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025, which serves as the primary...
This federal contract award to Amerisourcebergen Drug Corporation, Corporate Office Division, is for the provision of pharmaceutical products, including the medication RINVOQ ER 30 MG TABLET, to the Defense Logistics Agency (DLA). The contract, valued at $11,381.52, is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,015.85 firm fixed price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,658.76 firm fixed-price delivery order is for the supply of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. The award has an ultimate completion date of October 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award, valued at $9,023.13, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is made under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for AmerisourceBergen to provide a range of...
This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.89 firm fixed price delivery order is for RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,307.37 firm fixed-price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $6,015.42, is a delivery order issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FEXS1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,007.71 firm fixed price delivery order is for the supply of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen, as a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill these types of government contracts, supporting the DLA's mission to provide essential medical commodities to the U.S. Armed Forces and other government agencies.

Generated 9/17/24, 9:15 AM